RxDoctor Payments Data

Nauman Siddiqi, MD

Cardiovascular Disease · Irving, TXNPI 1033381546

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 70.2% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $6,971 and has fallen 96.5% since, to $245 in 2025.

$10,293in general payments, 2019–2025

Across 127 payments — averaging $81.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$7K
  • Edwards Lifesciences$860
  • Medtronic$842
  • Abbott$811
  • Philips North America LLC$123
  • Abiomed$90
  • plus $338 from 11 others

What the payments were for

  • Consulting fees$4,80047%
  • Travel & lodging$1,07610%
  • Food & beverage$4,40243%
  • Education$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,293 in reported general payments places this provider in the 75th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas →

Medicare billing

Part B allowed, 2024
$110,909
Medicare patients
249
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Irving

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →